Zura Bio Limited (ZURA)
NASDAQ: ZURA
· Real-Time Price · USD
3.43
-0.28 (-7.55%)
At close: Oct 16, 2025, 3:59 PM
3.41
-0.58%
After-hours: Oct 16, 2025, 07:54 PM EDT
-7.55% (1D)
| Bid | 3.33 |
| Market Cap | 223.01M |
| Revenue (ttm) | 2K |
| Net Income (ttm) | -67.76M |
| EPS (ttm) | -0.74 |
| PE Ratio (ttm) | -4.64 |
| Forward PE | -4.59 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 3.59 |
| Volume | 570,071 |
| Avg. Volume (20D) | 1,747,526 |
| Open | 3.71 |
| Previous Close | 3.71 |
| Day's Range | 3.41 - 3.73 |
| 52-Week Range | 0.97 - 5.07 |
| Beta | 0.25 |
| Ex-Dividend Date | n/a |
About ZURA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ZURA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ZURA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
-10.07%
Zura Bio shares are trading lower after the compan...
Unlock content with
Pro Subscription
2 months ago · businesswire.com
Zura Bio Reports Second Quarter 2025 Financial Results and Recent Corporate UpdatesHENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company dedicated to developing novel dual...
3 months ago · businesswire.com
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)HENDERSON, Nev.--(BUSINESS WIRE)---- $ZURA #TeamZura--Zura Bio Limited (Nasdaq: ZURA) (“Zura Bio” or the “Company”), a clinical-stage, multi-asset immunology company developing novel dual-pathway anti...